Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2.

NCT04479163 is registered in ClinicalTrials.gov with Fundacion Infant as lead sponsor.

NCT NCT04479163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04479163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2.
Lead sponsor
Fundacion Infant
Phase
Not applicable
Overall status
Completed
Start date
June 4, 2020
Completion date
October 25, 2020
Enrollment
165 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

covid